We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Centers for Medicare & Medicaid Services (CMS) is encouraging states to band together to negotiate deeper discounts from pharmaceutical firms on prescription drugs purchased under the Medicaid program.
ArthroCare has reached a definitive agreement to purchase soft tissue orthopedic device manufacturer Opus Medical for $130 million in cash, stock and delayed payments, the company announced Sept. 7.
Seeking to boost supply chain security, a Florida drug distributor is launching a pilot test of DataDot identification technology to authenticate pharmaceutical products.
Indiana will move to import prescription drugs from Canada if the federal government doesn’t act by next March to lower drug prices, according to the state’s top elected official.
The U.S. Pharmacopeia’s (USP’s) draft model guidelines for Medicare drug formularies fail to provide patients with access to needed medicines and should undergo a comprehensive revision, PhRMA contends.
Editors of some of the most prominent medical journals will no longer publish the results of clinical trials unless the studies first have been registered at a publicly accessible online database.
The U.S. Air Force no longer will dispense some widely used, but expensive, brand products under new formulary guidelines that favor generics and lower-cost brand drugs.
Lawmakers in West Virginia this month will consider adopting Australia’s method of determining drug prices — a move that could reward drugmakers for offering innovative products while forcing firms to provide the lowest price on products that offer few new benefits.